Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

463 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer.
Xie W, Ravi P, Buyse M, Halabi S, Kantoff P, Sartor O, Soule H, Clarke N, Dignam J, James N, Fizazi K, Gillessen S, Mottet N, Murphy L, Parulekar W, Sandler H, Tombal B, Williams S, Sweeney CJ. Xie W, et al. Among authors: buyse m. Ann Oncol. 2024 Mar;35(3):285-292. doi: 10.1016/j.annonc.2023.11.017. Epub 2023 Dec 5. Ann Oncol. 2024. PMID: 38061427
Challenges and Opportunities in Establishing Appropriate Intermediate Endpoints Reflecting Patient Benefit: A Roadmap for Research and Clinical Application in Nonmetastatic Prostate Cancer.
Brookman-May SD, Buyse M, Freedland SJ, Miladinovic B, Zhang K, Fendler WP, Feng F, Sartor O, Sweeney CJ. Brookman-May SD, et al. Among authors: buyse m. Eur Urol. 2024 May 17:S0302-2838(24)02348-0. doi: 10.1016/j.eururo.2024.04.024. Online ahead of print. Eur Urol. 2024. PMID: 38762392
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database.
Karapetis CS, Liu H, Sorich MJ, Pederson LD, Van Cutsem E, Maughan T, Douillard JY, O'Callaghan CJ, Jonker D, Bokemeyer C, Sobrero A, Cremolini C, Chibaudel B, Zalcberg J, Adams R, Buyse M, Peeters M, Yoshino T, de Gramont A, Shi Q. Karapetis CS, et al. Among authors: buyse m. Br J Cancer. 2024 May;130(8):1269-1278. doi: 10.1038/s41416-024-02604-y. Epub 2024 Feb 24. Br J Cancer. 2024. PMID: 38402342 Free PMC article. Clinical Trial.
Trial Design for Cancer Immunotherapy: A Methodological Toolkit.
Saad ED, Coart E, Deltuvaite-Thomas V, Garcia-Barrado L, Burzykowski T, Buyse M. Saad ED, et al. Among authors: buyse m. Cancers (Basel). 2023 Sep 21;15(18):4669. doi: 10.3390/cancers15184669. Cancers (Basel). 2023. PMID: 37760636 Free PMC article. Review.
On Enhancing Clinical Trial Data Sharing.
Buyse M. Buyse M. JAMA Oncol. 2023 Dec 1;9(12):1627-1628. doi: 10.1001/jamaoncol.2023.3859. JAMA Oncol. 2023. PMID: 37796491 No abstract available.
Minimization in randomized clinical trials.
Coart E, Bamps P, Quinaux E, Sturbois G, Saad ED, Burzykowski T, Buyse M. Coart E, et al. Among authors: buyse m. Stat Med. 2023 Dec 10;42(28):5285-5311. doi: 10.1002/sim.9916. Epub 2023 Oct 23. Stat Med. 2023. PMID: 37867447
Restricted Net Treatment Benefit in oncology.
Piffoux M, Ozenne B, De Backer M, Buyse M, Chiem JC, Péron J. Piffoux M, et al. Among authors: buyse m. J Clin Epidemiol. 2024 Apr 1;170:111340. doi: 10.1016/j.jclinepi.2024.111340. Online ahead of print. J Clin Epidemiol. 2024. PMID: 38570079 Free article.
Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials.
Ravi P, Xie W, Buyse M, Halabi S, Kantoff PW, Sartor O, Attard G, Clarke N, D'Amico A, Dignam J, James N, Fizazi K, Gillessen S, Parulekar W, Sandler H, Spratt DE, Sydes MR, Tombal B, Williams S, Sweeney CJ. Ravi P, et al. Among authors: buyse m. Eur Urol. 2024 May 21:S0302-2838(24)02380-7. doi: 10.1016/j.eururo.2024.04.038. Online ahead of print. Eur Urol. 2024. PMID: 38777647
Sexual dysfunction in cystic fibrosis.
Ramel S, Gueganton L, Nowak E, Bihan JL, Arnouat B, Belleguic C, Danner-Boucher I, Mankikian J, Payet A, Urban T, Buyse M, Hubeaux K. Ramel S, et al. Among authors: buyse m. J Cyst Fibros. 2024 Apr 29:S1569-1993(24)00056-0. doi: 10.1016/j.jcf.2024.04.011. Online ahead of print. J Cyst Fibros. 2024. PMID: 38688746
463 results